Microbial Translocation Is Associated with Extensive Immune Activation in Dengue Virus Infected Patients with Severe Disease

PLoS Neglected Tropical Diseases

Volumn 7, Issue 5, 2013, Pages

  van de Weg, Cornelia A M ^a   Pannuti, Cláudio S ^b   de Araújo, Evaldo S A ^b,c   van den Ham, Henk Jan ^a   Andeweg, Arno C ^a   Boas, Lucy S V ^b   Felix, Alvina C ^b   Carvalho, Karina I ^b   de Matos, Andreia M ^b   Levi, José E ^b   Romano, Camila M ^b   Centrone, Cristiane C ^b   de Lima Rodrigues, Celia L ^b   Luna, Expedito ^b   van Gorp, Eric C M ^a   Osterhaus, Albert D M E ^a   Martina, Byron E E ^a   Kallas, Esper G ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c HOSPITAL ANA COSTA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; ENDOTOXIN; EPIDERMAL GROWTH FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SCATTER FACTOR;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; CHILD; CLUSTER ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DENGUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SHOCK; VIRUS LOAD;

EID: 84878485590     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002236     Document Type: Article

References (45)

1. Romano CM, de Matos AM, Araujo ES, Villas-Boas LS, da Silva WC, et al. (2010) Characterization of Dengue virus type 2: new insights on the 2010 Brazilian epidemic. PLoS One 5: e11811.
2. Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, et al. (2002) Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 185: 1213-1221.
3. Martina BE, Koraka P, Osterhaus AD, (2009) Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 22: 564-581.
4. Halstead SB, (2003) Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 60: 421-467.
5. Rothman AL, (2011) Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11: 532-543.
6. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371.
7. Hofer U, Speck RF, (2009) Disturbance of the gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection. Semin Immunopathol 31: 257-266.
8. van de Weg CA, Koraka P, van Gorp EC, Mairuhu AT, Supriatna M, et al. (2012) Lipopolysaccharide levels are elevated in dengue virus infected patients and correlate with disease severity. J Clin Virol 53: 38-42.
9. van de Weg CA, van Gorp EC, Supriatna M, Soemantri A, Osterhaus AD, et al. (2012) Evaluation of the 2009 WHO dengue case classification in an Indonesian pediatric cohort. Am J Trop Med Hyg 86: 166-170.
10. World Health Organization (2009) Dengue hemorrhagic fever: diagnosis, treatment, prevention and control (new edition). Geneva.
11. de Souza VA, Fernandes S, Araujo ES, Tateno AF, Oliveira OM, et al. (2004) Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections. J Clin Microbiol 42: 1782-1784.
12. Felix AC, Romano CM, Centrone Cde C, Rodrigues CL, Villas-Boas L, et al. (2012) Low sensitivity of NS1 protein tests evidenced during a dengue type 2 virus outbreak in Santos, Brazil, in 2010. Clin Vaccine Immunol 19: 1972-1976.
13. Harris E, Roberts TG, Smith L, Selle J, Kramer LD, et al. (1998) Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR. J Clin Microbiol 36: 2634-2639.
14. van den Ham HJ, de Jager W, Bijlsma JW, Prakken BJ, de Boer RJ, (2009) Differential cytokine profiles in juvenile idiopathic arthritis subtypes revealed by cluster analysis. Rheumatology (Oxford) 48: 899-905.
15. Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, et al. (1999) Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 180: 1584-1589.
16. Landmann R, Zimmerli W, Sansano S, Link S, Hahn A, et al. (1995) Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J Infect Dis 171: 639-644.
17. Bukh AR, Melchjorsen J, Offersen R, Jensen JM, Toft L, et al. (2011) Endotoxemia is associated with altered innate and adaptive immune responses in untreated HIV-1 infected individuals. PLoS One 6: e21275.
18. Redd AD, Dabitao D, Bream JH, Charvat B, Laeyendecker O, et al. (2009) Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa. Proc Natl Acad Sci U S A 106: 6718-6723.
19. Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, et al. (2012) Into the eye of the cytokine storm. Microbiol Mol Biol Rev 76: 16-32.
20. Santos-Oliveira JR, Regis EG, Leal CR, Cunha RV, Bozza PT, et al. (2011) Evidence that lipopolisaccharide may contribute to the cytokine storm and cellular activation in patients with visceral leishmaniasis. PLoS Negl Trop Dis 5: e1198.
21. Wang W, Deng M, Liu X, Ai W, Tang Q, et al. (2011) TLR4 activation induces nontolerant inflammatory response in endothelial cells. Inflammation 34: 509-518.
22. Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, et al. (2008) Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol 294: C675-682.
23. Bosisio D, Polentarutti N, Sironi M, Bernasconi S, Miyake K, et al. (2002) Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 99: 3427-3431.
24. Chen YC, Wang SY, (2002) Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide. J Virol 76: 9877-9887.
25. Chen YC, Wang SY, King CC, (1999) Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism. J Virol 73: 2650-2657.
26. Tang Y, Kou Z, Zhang F, Yao X, Liu S, et al. (2010) Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients. PLoS One 5: e15631.
27. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, et al. (1991) Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest 88: 1473-1480.
28. Perez AB, Garcia G, Sierra B, Alvarez M, Vazquez S, et al. (2004) IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol 73: 230-234.
29. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, et al. (1999) Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol 59: 329-334.
30. Pacsa AS, Agarwal R, Elbishbishi EA, Chaturvedi UC, Nagar R, et al. (2000) Role of interleukin-12 in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 28: 151-155.
31. Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, et al. (2008) Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 8: 86.
32. Sierra B, Perez AB, Vogt K, Garcia G, Schmolke K, et al. (2010) MCP-1 and MIP-1alpha expression in a model resembling early immune response to dengue. Cytokine 52: 175-183.
33. Lee YR, Liu MT, Lei HY, Liu CC, Wu JM, et al. (2006) MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J Gen Virol 87: 3623-3630.
34. Azeredo EL, Zagne SM, Santiago MA, Gouvea AS, Santana AA, et al. (2001) Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology 204: 494-507.
35. Srikiatkhachorn A, Ajariyakhajorn C, Endy TP, Kalayanarooj S, Libraty DH, et al. (2007) Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic Fever. J Virol 81: 1592-1600.
36. Chen JP, Lu HL, Lai SL, Campanella GS, Sung JM, et al. (2006) Dengue virus induces expression of CXC chemokine ligand 10/IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate. J Immunol 177: 3185-3192.
37. Murphy KT, Walport PM (2008) Janeway's immunobiology. New York: Garland Science.
38. Saraiva M, O'Garra A, (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10: 170-181.
39. Hober D, Poli L, Roblin B, Gestas P, Chungue E, et al. (1993) Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am J Trop Med Hyg 48: 324-331.
40. Nguyen TH, Lei HY, Nguyen TL, Lin YS, Huang KJ, et al. (2004) Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis 189: 221-232.
41. Suharti C, van Gorp EC, Dolmans WM, Setiati TE, Hack CE, et al. (2003) Cytokine patterns during dengue shock syndrome. Eur Cytokine Netw 14: 172-177.
42. Bethell DB, Flobbe K, Cao XT, Day NP, Pham TP, et al. (1998) Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infect Dis 177: 778-782.
43. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, et al. (1999) Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 179: 755-762.
44. Caruso C, Candore G, Cigna D, Colucci AT, Modica MA, (1993) Biological significance of soluble IL-2 receptor. Mediators Inflamm 2: 3-21.
45. John CC, Opika-Opoka R, Byarugaba J, Idro R, Boivin MJ, (2006) Low levels of RANTES are associated with mortality in children with cerebral malaria. J Infect Dis 194: 837-845.